DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
3.925
+0.195 (5.23%)
At close: Jun 25, 2025, 4:00 PM
3.950
+0.025 (0.64%)
After-hours: Jun 25, 2025, 7:30 PM EDT

DiaMedica Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-27-24.44-19.38-13.68-13.59-12.29
Upgrade
Depreciation & Amortization
0.040.040.030.030.020.02
Upgrade
Loss (Gain) From Sale of Investments
-1.28-1.34-1.22-0.010.16-0
Upgrade
Stock-Based Compensation
2.462.091.681.51.561.84
Upgrade
Other Operating Activities
0.080.080.070.060.060.05
Upgrade
Change in Accounts Receivable
0.150.13-0.290.050.210.48
Upgrade
Change in Accounts Payable
0.790.010.190.23-0.590.92
Upgrade
Change in Other Net Operating Assets
2.181.370.190.31-0.08-0.21
Upgrade
Operating Cash Flow
-22.57-22.08-18.73-11.51-12.25-9.19
Upgrade
Capital Expenditures
-0.03-0.03-0.02-0.08-0.02-0.05
Upgrade
Sale of Property, Plant & Equipment
----00.02
Upgrade
Investment in Securities
11.018.59-18.2811.62-20.52-16.1
Upgrade
Investing Cash Flow
10.988.56-18.311.54-20.54-16.13
Upgrade
Long-Term Debt Repaid
--0.01-0.01-0.01-0.01-0.01
Upgrade
Net Debt Issued (Repaid)
-0.01-0.01-0.01-0.01-0.01-0.01
Upgrade
Issuance of Common Stock
12.11236.85-30.2428.85
Upgrade
Other Financing Activities
-----0.15-
Upgrade
Financing Cash Flow
12.0911.9936.84-0.0130.0928.85
Upgrade
Net Cash Flow
0.49-1.52-0.190.02-2.73.53
Upgrade
Free Cash Flow
-22.6-22.1-18.75-11.59-12.27-9.23
Upgrade
Free Cash Flow Per Share
-0.54-0.55-0.58-0.44-0.59-0.59
Upgrade
Cash Income Tax Paid
0.030.030.030.030.030.04
Upgrade
Levered Free Cash Flow
-13.8-11.68-11.45-6.69-7.37-4.87
Upgrade
Unlevered Free Cash Flow
-13.8-11.68-11.45-6.69-7.37-4.87
Upgrade
Change in Net Working Capital
-1.9-2.9-0.16-0.620.4-1.25
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q